TipRanks
Advertisement
Advertisement

QNRX Stock Latest News

Quoin Pharmaceuticals Gains EMA Orphan Status for QRX003
Company AnnouncementsQuoin Pharmaceuticals Gains EMA Orphan Status for QRX003
13m ago
8K
QNRX
Quoin’s QRX003 granted Orphan Drug Designation in Europe
PremiumThe Fly
Quoin’s QRX003 granted Orphan Drug Designation in Europe
36m ago
QNRX
Quoin Pharmaceuticals initiated with a Buy at BTIG
PremiumThe Fly
Quoin Pharmaceuticals initiated with a Buy at BTIG
2d ago
QNRX
Four Small-Cap Stocks Report New Developments (CHGA, QNRX, MYSE, LNKS)
PremiumTipRanks Newswire
Four Small-Cap Stocks Report New Developments (CHGA, QNRX, MYSE, LNKS)
20d ago
CHGA
LNKS
Quoin Pharmaceuticals initiated with a Buy at Lake Street
PremiumThe Fly
Quoin Pharmaceuticals initiated with a Buy at Lake Street
21d ago
QNRX
Quoin Gains FDA Fast Track for QRX003 Skin Therapy
PremiumCompany AnnouncementsQuoin Gains FDA Fast Track for QRX003 Skin Therapy
22d ago
8K
QNRX
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
Premium
TipRanks Newswire
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome
22d ago
QNRX
Quoin Pharmaceuticals announces U.S. FDA granted FTD to QRX003
Premium
The Fly
Quoin Pharmaceuticals announces U.S. FDA granted FTD to QRX003
22d ago
QNRX
Quoin Pharmaceuticals registers to sell 9.37M ADRs for holders
PremiumThe Fly
Quoin Pharmaceuticals registers to sell 9.37M ADRs for holders
26d ago
QNRX
Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation
PremiumCompany Announcements
Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation
1M ago
8K
QNRX
Quoin Pharmaceuticals granted Rare Pediatric Disease Designation for QRX003
PremiumThe Fly
Quoin Pharmaceuticals granted Rare Pediatric Disease Designation for QRX003
1M ago
QNRX
Quoin Reports Positive Interim QRX003 Netherton Data
PremiumCompany Announcements
Quoin Reports Positive Interim QRX003 Netherton Data
2M ago
8K
QNRX
Quoin Pharmaceuticals announces $50M private placement
PremiumThe FlyQuoin Pharmaceuticals announces $50M private placement
2M ago
QNRX
Quoin Pharmaceuticals reports ‘positive’ data from Phase 2/3 study of QRX003
Premium
The Fly
Quoin Pharmaceuticals reports ‘positive’ data from Phase 2/3 study of QRX003
2M ago
QNRX
Quoin Pharmaceuticals Shareholders Approve Governance and Compensation Changes
Premium
Company Announcements
Quoin Pharmaceuticals Shareholders Approve Governance and Compensation Changes
2M ago
8K
QNRX
Quoin Pharmaceuticals reports Q2 EPS ($1.90), consensus ($1.77)
PremiumThe Fly
Quoin Pharmaceuticals reports Q2 EPS ($1.90), consensus ($1.77)
2M ago
QNRX
QNRX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
QNRX Upcoming Earnings Report: What to Expect?
2M ago
QNRX
Quoin Pharmaceuticals announces FDA clearance of QRX003 IND application
PremiumThe Fly
Quoin Pharmaceuticals announces FDA clearance of QRX003 IND application
3M ago
QNRX
Quoin Pharmaceuticals receives notice of allowance for QRX003 patent
PremiumThe Fly
Quoin Pharmaceuticals receives notice of allowance for QRX003 patent
4M ago
QNRX
Naz Rahman Maintains Buy on Quoin as QYLEKI Progress Offsets Financing Risks, While Cutting 12-Month Price Target from $40 to $16
PremiumRatingsNaz Rahman Maintains Buy on Quoin as QYLEKI Progress Offsets Financing Risks, While Cutting 12-Month Price Target from $40 to $16
4M ago
QNRX
Quoin Advances QYLEKI Toward First Netherton Therapy
Premium
Company Announcements
Quoin Advances QYLEKI Toward First Netherton Therapy
4M ago
8K
QNRX
Quoin Pharmaceuticals announces conditional FDA approval for Qyleki brand name
Premium
The Fly
Quoin Pharmaceuticals announces conditional FDA approval for Qyleki brand name
4M ago
QNRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >